Daewoong Co., Ltd. (KRX:003090)

Market Cap	807.59B
Revenue (ttm)	1.94T
Net Income (ttm)	57.89B
Shares Out	40.89M
EPS (ttm)	1,415.61
PE Ratio	13.95
Forward PE	6.67
Dividend	100.00 (0.51%)
Ex-Dividend Date	Dec 27, 2024

Volume	34,201
Average Volume	26,946
Open	19,690
Previous Close	19,660
Day's Range	19,580 - 20,100
52-Week Range	15,050 - 28,100
Beta	1.53
RSI	52.68
Earnings Date	May 14, 2025

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam, South...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 356
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2024, Daewoong's revenue was 1.94 trillion, an increase of 6.79% compared to the previous year's 1.81 trillion. Earnings were 57.89 billion, a decrease of -62.08%.